Search results for: act pediatric

Although the primary focus of this Contract is to support the Best Pharmaceuticals for Children Act-Pediatric Trials Network clinical activities, NICHD also anticipates the need to utilize this Contract to acquire similar types of support for other NICHD pediatric drug development activities.BPCA 2017 authorizes NICHD to identify therapeutic gaps in pediatrics, which are pediatric diseases, disorders or conditions where more complete knowledge and

2020.500-COVID-19 - BEST PHARMACEUTICALS FOR CHILDREN ACT PEDIATRIC TRIALS NETWORK - COVID-19 STUDIES Solicitation ID/Procurement Identifier: 75N94018D00003 Ultimate Completion Date: Wed Sep 20 17:00:00 GMT 2023

Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)

Access to these data also increase the FDA’s ability to request regulatory impact studies such as those authorized under Best Pharmaceuticals for Children Act (BPCA) and Pediatric Research Equity Act (PREA) to better understand the usefulness of drug labeling to clinicians. This can be done by examining actual use of products in hospitals in relation to recommended labeling.

The Senior PMTCT/Pediatric Technical Advisor (Senior Advisor) will provide technicalleadership to drive programmatic improvement in pediatric care and treatment and PMTCT portfolios. The Senior Advisor will act as the technical and programmatic lead in Pediatric care with emphasis on newborn and child health issues including HIV/AIDS pediatrics and PMTCT services that includes programmatic linkages with USAID Health and PEPFAR Teams.

The successful candidate will act as the scientific and programmatic lead in Pediatric care with emphasis on newborn and child health issues and WASH in a multisectoral programming environment for child survival. 

The successful candidate will act as the scientific and programmatic lead in Pediatric care with emphasis on newborn and child health issues and WASH in a multisectoral programming environment for child survival.